The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …

A leading think tank has marked the coalition government’s health policy with what amounts to a C+ in its mid-term …

Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …

ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …

Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …

Jim Easton has stepped down from his role as national director: Transformation at the NHS Commissioning Board (CB) and his …

In the noisy and continuing debate over health reform, it is worth remembering the aim of the coalition government’s health …

The NHS Commissioning Board (NHS CB) has made several national appointments to the Medical Directorate. Barry Cockcroft (currently chief dental …

An NHS initative which is supposed to drive public health forward is in danger of having only a limited impact, …

Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …

The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …